Stream 1 of the EiR program helps Temerty Medicine ventures achieve a pivotal commercialization milestone by providing:
Up to $10,000 in non-dilutive funding.
Up to 6 months, with the possibility of a 3-month no-cost extension if required.
Funding must be used to hire an SME or consultant to help the venture achieve a clearly defined milestone within a 6-month period. The engagement should directly advance the venture’s commercialization or translational readiness.
Examples of supported activities: regulatory strategy, reimbursement planning, business model validation, legal and contracts/licensing guidance, product development, etc.
The application package (one PDF file) should include the following:
Applications are accepted on a triannual basis (January, May, September). The upcoming submission deadlines are included below:
Please contact Andrea Hung (andrea.hung@utoronto.ca) for access to the application form. Complete application packages should be submitted to Andrea Hung (andrea.hung@utoronto.ca). Select applicants will be invited for an interview.
Please review our FAQ page. For questions or clarifications, please contact Andrea Hung (andrea.hung@utoronto.ca).